Strategies to enhance CAR-T persistenceYue Liu, Xi Zhang, Lingna An et al.|Biomarker Research|2022Cited by 90
Current status and prospects of hematopoietic stem cell transplantation in ChinaXiaoqi Wang, Xi Zhang, Ruihao Huang et al.|Chinese Medical Journal|2022Cited by 40
Recent advances in ocular graft-versus-host diseaseXianjing Cheng, Xi Zhang, Ruihao Huang et al.|Frontiers in Immunology|2023Cited by 34
Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I TrialRuihao Huang, Xi Zhang, Qin Wen et al.|Blood|2022Cited by 33
Unity brings strength: Combination of CAR-T cell therapy and HSCTRuihao Huang, Xi Zhang, Xiaoqi Wang|Cancer Letters|2022Cited by 32